PLIANT THERAPEUTICS INC (PLRX) Stock Balance Sheet
NASDAQ:PLRX - Nasdaq - US7291391057 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 79.62M | 63.23M | 33.70M | 51.70M | 50.90M | |||
| Marketable Securities | 324.90M | 431.01M | 297.50M | 148.90M | 226.00M | |||
| Receivables | 2.22M | 3.00M | 2.10M | 2.10M | 9.40M | |||
| Other Current Assets | 3.30M | 8.26M | 7.10M | 6.80M | 4.50M | |||
| Total Current Assets | 410.03M | 505.50M | 340.30M | 209.40M | 290.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 33.73M | 4.78M | 9.90M | 10.90M | 4.30M | |||
| Other Non-Current Assets | 1.91M | 1.87M | 400.00K | 800.00K | 500.00K | |||
| Total Non-Current Assets | 35.63M | 6.65M | 10.30M | 11.80M | 4.70M | |||
| TOTAL ASSETS | 445.67M | 512.15M | 350.60M | 221.20M | 295.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 1.87M | N/A | |||
| Accrued Expenses | 33.06M | 23.99M | 22.30M | 13.90M | 9.60M | |||
| Accounts Payable | 6.89M | 4.53M | 1.60M | 3.00M | 2.00M | |||
| Total Current Liabilities | 39.95M | 28.52M | 23.90M | 16.80M | 11.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 30.14M | 10.05M | 9.90M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 29.75M | 0.00 | 3.40M | 5.30M | 900.00K | |||
| Total Non-Current Liabilities | 59.89M | 10.05M | 13.40M | 5.40M | 900.00K | |||
| TOTAL LIABILITIES | 99.84M | 38.58M | 37.30M | 22.20M | 12.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -660.32M | -499.75M | -338.40M | -215.10M | -117.80M | |||
| Additional Paid In Capital | 1.01B | 972.97M | 653.70M | 414.30M | 400.90M | |||
| Common Shares | 6.00K | 6.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 848.00K | 345.00K | -2.00M | -200.00K | 0.00 | |||
| Shares Outstanding | 60.85M | 59.92M | 48.90M | 36.10M | 35.60M | |||
| Tangible Book Value per Share | 5.68 | 7.90 | 6.41 | 5.52 | 7.95 | |||
| Total Shareholders' Equity | 345.82M | 473.58M | 313.30M | 199.10M | 283.10M | |||
| TOTAL LIABILITIES AND EQUITY | 445.67M | 512.15M | 350.60M | 221.20M | 295.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.09 | 0.02 | 0.03 | N/A | N/A | |||
| Current Ratio | 10.26 | 17.72 | 14.24 | 12.46 | 25.07 | |||
| Return On Assets (ROA) | -45.25% | -31.50% | -35.17% | -43.97% | -14.05% | |||
| Return On Equity (ROE) | -58.32% | -34.07% | -39.36% | -48.85% | -14.67% | |||
All data in USD , ROIC based on taxRate of 0.21